v3.26.1
Business Segment: (Details)
3 Months Ended 6 Months Ended
Jun. 30, 2026
USD ($)
Jun. 30, 2025
USD ($)
Jun. 30, 2026
USD ($)
segment
Jun. 30, 2025
USD ($)
Business Segment:        
Number of operating segments | segment     1  
Number of reportable segments | segment     1  
Total research and development expenses $ 31,855 $ 148,555 $ 60,455 $ 209,371
Single business segment        
Business Segment:        
External clinical development expenses 10,353 84,457 20,704 110,648
Personnel related and stock-based compensation 7,013 44,258 9,525 57,083
Other research and development expenses 14,489 19,840 30,226 41,640
Total research and development expenses $ 31,855 $ 148,555 $ 60,455 $ 209,371